Difference between revisions of "Team:Freiburg/Project/Overview"
| Line 14: | Line 14: | ||
</div> | </div> | ||
<p> | <p> | ||
| − | The DiaCHIP is a new tool to simultaneously detect antibodies | + | The DiaCHIP is a new tool to simultaneously detect antibodies corresponding to different diseases in blood sera. It may greatly simplify broad band screenings, detection of autoimmune diseases and determination of vaccination status. Essential for our project idea is the combination of protein synthesis directly in the diagnostic device using a new and label-free detection system so simple that it can easily be rebuild by future iGEM teams. |
</p> | </p> | ||
</div> | </div> | ||
| Line 22: | Line 22: | ||
<div class="level2"> | <div class="level2"> | ||
<p> | <p> | ||
| − | As the DiaCHIP relies on antibody-antigen | + | As the DiaCHIP relies on antibody-antigen interactions, the antigens first have to be synthesized and immobilized inside the device. Given that the whole device is a microfluidic system, it was most convenient to do this directly in the flow-chamber, where detection will finally take place. |
| − | The flow-chamber consists of two surfaces separated by a gap that can be flushed with liquids. On the | + | The flow-chamber consists of two surfaces separated by a gap that can be flushed with liquids. On the one surface DNA molecules providing the information for the antigens are attached and can be transcribed and translated into protein when a cell-free expression mix is flushed through the chamber. Proteins then diffuse until reaching the second surface that specifically captures the proteins encoded by the immobilized DNA. After several washing steps to remove remaining expression-mix the flow-chamber is coated with antigens and ready for detection. |
</p> | </p> | ||
</div> | </div> | ||
| Line 32: | Line 32: | ||
<div class="level2"> | <div class="level2"> | ||
<p> | <p> | ||
| − | With the iRIf system it is possible to record small changes in layer thickness. The binding of an antibody from the blood serum flushed through the chamber increases the thickness of the | + | With the iRIf system it is possible to record small changes in layer thickness. The binding of an antibody from the blood serum flushed through the chamber to the according antigen increases the thickness of the protein surface so that interaction events can be measured label-free and in real-time. |
</p> | </p> | ||
<p> | <p> | ||
| − | But we didn't stop | + | But we didn't stop thinking about the device: <a href="https://2015.igem.org/Team:Freiburg/Results/Overview">We detected antibodies in our own blood!</a> |
</p> | </p> | ||
</div> | </div> | ||
Revision as of 11:43, 4 September 2015
Project overview: The DiaCHIP
The DiaCHIP is a new tool to simultaneously detect antibodies corresponding to different diseases in blood sera. It may greatly simplify broad band screenings, detection of autoimmune diseases and determination of vaccination status. Essential for our project idea is the combination of protein synthesis directly in the diagnostic device using a new and label-free detection system so simple that it can easily be rebuild by future iGEM teams.
Preparing the DiaCHIP
As the DiaCHIP relies on antibody-antigen interactions, the antigens first have to be synthesized and immobilized inside the device. Given that the whole device is a microfluidic system, it was most convenient to do this directly in the flow-chamber, where detection will finally take place. The flow-chamber consists of two surfaces separated by a gap that can be flushed with liquids. On the one surface DNA molecules providing the information for the antigens are attached and can be transcribed and translated into protein when a cell-free expression mix is flushed through the chamber. Proteins then diffuse until reaching the second surface that specifically captures the proteins encoded by the immobilized DNA. After several washing steps to remove remaining expression-mix the flow-chamber is coated with antigens and ready for detection.
Measuring
With the iRIf system it is possible to record small changes in layer thickness. The binding of an antibody from the blood serum flushed through the chamber to the according antigen increases the thickness of the protein surface so that interaction events can be measured label-free and in real-time.
But we didn't stop thinking about the device: We detected antibodies in our own blood!
